Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients.

CONCLUSIONS: CD200(+) and/or CD56(+) positive expression in B-ALL patients at diagnosis is a poor prognostic biomarker. Identification of CD200(+) and CD56(+) expression at diagnosis is recommended for a better stratification of adult B-ALL patients. PMID: 29161980 [PubMed - as supplied by publisher]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research